Loading…
Evoq Remedies (BSE 543500)₹1.60+3.90%Trading & Distributors
At the end of the Mar 2026 quarter, Evoq Remedies' shareholders were: promoters 0.02%, public 99.98%. Promoter holding is down 11.16 percentage points from 11.18% a quarter earlier. 0.00% of promoter shares were pledged. It had 1,654 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 73.50% | 20.50% | 11.18% | 11.18% | 11.18% | 11.18% | 0.02% |
| Public | 26.50% | 79.50% | 88.82% | 88.82% | 88.82% | 88.82% | 99.98% |
| Promoter shares pledged | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 726 | 1,671 | 1,587 | 1,576 | 1,722 | 1,678 | 1,654 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Dhruv Ganji | Public | 11.37% | — |
| Prashant Sevantikar | Public | 11.34% | — |
| Surya Prakash Jethlia | Public | 2.63% | — |
| Nilesh M Suhagiya | Public | 2.08% | — |
| Anand Mohan | Public | 1.52% | — |
| Yashiv Holdings Private Limited | Public | 1.45% | — |
| Pattabiraman N R | Public | 1.39% | — |
| Gayathri Radhakrishnan | Public | 1.05% | — |
| Ambalal Karamshibhai Senghani | Public | 1.03% | — |
| Bhumishth Narendrabhai Patel | Promoter | 0.01% | — |
| Patel Payal Bhumishth | Promoter | 0.00% | — |
Promoters held 0.02% of Evoq Remedies at the end of the Mar 2026 quarter, down 11.16 percentage points from 11.18% a year earlier.
No. The Mar 2026 filing shows no pledged promoter shares.
Evoq Remedies had 1,654 shareholders at the end of the Mar 2026 quarter, against 1,587 a year earlier.
Dhruv Ganji (Public) held 11.37% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.